Literature DB >> 10590037

Concentrations of granulocyte colony-stimulating factor in human milk after in vitro simulations of digestion.

D A Calhoun1, M Lunøe, Y Du, S L Staba, R D Christensen.   

Abstract

Human milk contains proteins that survive digestion in the neonatal gastrointestinal tract. Our group and others have reported that granulocyte colony-stimulating factor (G-CSF), a hematopoietic cytokine that influences neutrophil proliferation and differentiation, is present in human milk. We also reported that specific receptors for G-CSF are expressed on the villous enterocytes of neonates. However, the physiologic role of milk-borne G-CSF is not known. Thus, we sought to evaluate the capacity of human milk to protect G-CSF against proteolytic degradation after exposure to gastric secretions obtained from preterm (PT) and term (T) neonates at pH concentrations of 3.2, 5.8, and 7.4. Specifically, we examined degradation of 1) endogenous G-CSF in PT (n = 15) and T (n = 15) human milk; 2) recombinant human G-CSF (rhG-CSF) added to a protein-free buffer (n = 10, 5 PT and 5 T); and 3) rhG-CSF added to human milk (n = 12, 6 PT and 6 T), various commercially prepared infant formulas (n = 15), and cow's milk (n = 5). Endogenous G-CSF and rhG-CSF added to human milk resisted degradation at 1 and 2 h. However, when rhG-CSF was added to commercial formulas, >95% was degraded at 1 and 2 h at each pH level. Similarly, approximately 60% of rhG-CSF added to cow's milk was degraded at I and 2 h. We conclude that 1) endogenous G-CSF and rhG-CSF added to human milk are protected from degradation after exposure to gastric secretions at physiologic pH levels, 2) rhG-CSF added to infant formulas is not protected from degradation, and 3) it is likely that the G-CSF present in human milk is biologically available to the neonate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10590037     DOI: 10.1203/00006450-199912000-00021

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Protective effects of recombinant human granulocyte colony stimulating factor in a rat model of necrotizing enterocolitis.

Authors:  Fuat Emre Canpolat; Murat Yurdakök; Sule Ozsoy; Rifki Haziroğlu; Ayşe Korkmaz
Journal:  Pediatr Surg Int       Date:  2006-07-27       Impact factor: 1.827

2.  Lipid malabsorption persists after weaning in rats whose dams were given GLP-2 and dexamethasone.

Authors:  Claudiu Iordache; Laurie A Drozdowski; M Tom Clandinin; Gary Wild; Zoe Todd; Alan B R Thomson
Journal:  Lipids       Date:  2005-11       Impact factor: 1.880

Review 3.  The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

Authors:  Kathryn J Rowland; Pamela M Choi; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

Review 4.  Oropharyngeal administration of colostrum to extremely low birth weight infants: theoretical perspectives.

Authors:  N A Rodriguez; P P Meier; M W Groer; J M Zeller
Journal:  J Perinatol       Date:  2008-09-04       Impact factor: 2.521

Review 5.  Human Milk Growth Factors and Their Role in NEC Prevention: A Narrative Review.

Authors:  Daniel J York; Anne L Smazal; Daniel T Robinson; Isabelle G De Plaen
Journal:  Nutrients       Date:  2021-10-23       Impact factor: 5.717

Review 6.  Human Breast Milk: From Food to Active Immune Response With Disease Protection in Infants and Mothers.

Authors:  Gatien A G Lokossou; Léonce Kouakanou; Anne Schumacher; Ana C Zenclussen
Journal:  Front Immunol       Date:  2022-04-05       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.